Achilles Tendon Enthesitis and Disease Burden in Psoriatic Arthritis and Axial Spondyloarthritis: Baseline Results from a Randomized Controlled Trial

被引：0
作者：
Behrens, Frank [1 ]
Sewerin, Philipp [2 ,3 ]
de Miguel, Eugenio [4 ]
Patel, Yusuf [5 ]
Batalov, Anastas [6 ]
Dokoupilova, Eva [7 ]
Kleinmond, Christine [8 ]
Pournara, Effie [9 ]
Shekhawat, Ankita [10 ]
Jentzsch, Claudia [11 ]
Wiedon, Annette [11 ]
Baraliakos, Xenofon [12 ]
机构：
[1] Goethe Univ, CIRI Rheumatol & Fraunhofer TMP, Frankfurt, Germany
[2] Univ Hosp Dusseldorf, Dept Rheumatol, Dusseldorf, Germany
[3] Univ Hosp Dusseldorf, Hiller Res Unit, Dusseldorf, Germany
[4] Hosp Univ La Paz, Rheumatol Dept, Madrid, Spain
[5] Hull Univ, Teaching Hosp, Kingston Upon Hull, N Humberside, England
[6] Med Univ Plovdiv, Univ Hosp Kaspela, Plovdiv, Bulgaria
[7] Univ Vet & Pharmaceut Sci, Fac Pharm, Dept Pharmaceut, Med Plus Sro, Uherske Hradiste, Czech Republic
[8] ClinProject GmbH, Eurasburg, Germany
[9] Novartis Pharma AG, Basel, Switzerland
[10] Novartis Healthcare Pvt Ltd, Hyderabad, India
[11] Novartis Pharma GmbH, Nurnberg, Germany
[12] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet, Herne, Germany
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2503
引用
收藏
页数：3
相关论文
共 50 条
  • [41] COMPARING COMPOSITE MEASURES OF DISEASE ACTIVITY IN PSORIATIC ARTHRITIS: RESULTS FROM A RANDOMIZED PHASE 2 TRIAL WITH GUSELKUMAB
    Helliwell, Philip
    Deodhar, Atul
    Gottlieb, Alice B.
    Boehncke, Wolf-Henning
    Xu, Xie L.
    Xu, Stephen
    Wang, Yuhua
    Hsia, Elizabeth C.
    Gladman, Dafna D.
    Ritchlin, Christopher T.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1843 - 1843
  • [42] SAFETY PROFILE OF BIMEKIZUMAB AT WEEK 16 IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS: RESULTS FROM FOUR PLACEBO-CONTROLLED PHASE 3 STUDIES
    Poddubnyy, D.
    Gensler, L. S.
    Mease, P. J.
    Orbai, A. M.
    Warren, R. B.
    Ink, B.
    Massow, U.
    Assudani, D.
    Fleurinck, C.
    Shende, V.
    Smith, J.
    Peterson, L.
    White, K.
    Landewe, R. B. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1686 - 1687
  • [43] Impact of Peripheral Arthritis on Disease Activity Outcomes in Patients with Axial Spondyloarthritis, Peripheral Spondyloarthritis and Psoriatic Arthritis. Data from the ASAS-PerSpA Study
    Lopez Medina, Clementina
    Ramiro, Sofia
    Capelusnik, Dafne
    Molto, Anna
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1098 - 1100
  • [44] Efficacy of Secukinumab in Enthesitis-related Arthritis and Juvenile Psoriatic Arthritis Subtypes of Juvenile Idiopathic Arthritis: Results from a Randomized, Phase 3 Study
    Brunner, Hermine
    Chertok, Elena
    Dehoorne, Joke
    Horneff, Gerd
    Kallinich, Tilmann
    Louw, Ingrid
    Alessio, Maria
    Compeyrot-Lacassagne, Sandrine
    Lauwerys, Bernard
    Martin, Neil
    Marzan, Katherine
    Knibbe, W. Patrick
    Martin, Ruvie
    Zhu, Xuan
    Whelan, Sarah
    Pricop, Luminita
    Lovell, Daniel
    Martini, Alberto
    Ruperto, Nicola
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4382 - 4385
  • [45] Efficacy of adalimumab in the treatment of preradiographic axial spondyloarthritis: Results of a 12-week, randomized controlled trial.
    Haibel, Hildrun
    Rudwaleit, Martin
    Heldmann, Frank
    Listing, Joachim
    Wong, Robert
    Kupper, Hartmut
    Braun, Juergen
    Sieper, Joachim
    ARTHRITIS AND RHEUMATISM, 2006, 54 (12): : 4044 - 4045
  • [46] Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial)
    Uhrenholt, Line
    Schlemmer, Annette
    Hauge, Ellen-Margrethe
    Christensen, Robin
    Dreyer, Lene
    Suarez-Almazor, Maria E.
    Kristensen, Salome
    BMJ OPEN, 2019, 9 (07):
  • [47] DETERMINANTS OF GENERAL HEALTH AND HEALTH RELATED QUALITY OF LIFE IN AXIAL SPONDYLOARTHRITIS, PERIPHERAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS: RESULTS FROM THE ASAS-PERSPA STUDY
    Santos, H.
    Henriques, A. R.
    Dougados, M.
    Lopez-Medina, C.
    Canhao, H.
    Machado, P. M.
    Pimentel Santos, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 300 - 301
  • [48] Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (52-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Results from a Phase 3, Randomized, Controlled Trial
    Edwards, Christopher J.
    Aelion, Jacob A.
    Adebajo, Adewale O.
    Kivitz, Alan
    Bird, Paul
    Hu, ChiaChi
    Stevens, Randall M.
    Wells, Alvin
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S694 - S695
  • [49] The Effect of Probiotic Modulation of Enteral Dysbiosis on Disease Activity in Patients with Psoriatic Arthritis - A Randomized Controlled Trial
    Muralikrishnan, Anirudh Subramanian
    Dreo, Barbara
    Lackner, Angelika
    Husic, Rusmir
    Moazedi-Fuerst, Florentine
    Hermann, Josef
    Bosch, Philipp
    Fessler, Johannes
    Thiel, Jens
    Stradner, Martin
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1562 - 1564
  • [50] SECUKINUMAB, A HUMAN ANTI-INTERLEUKIN-17A MONOCLONAL ANTIBODY, SIGNIFICANTLY REDUCES PSORIASIS BURDEN IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM A PHASE 3 RANDOMIZED CONTROLLED TRIAL
    Nash, P.
    Gottlieb, A.
    Mease, P.
    McInnes, I.
    Kirkham, B.
    Kavanaugh, A.
    Rahman, P.
    Pricop, L.
    Yuan, J.
    Richards, H.
    Mpofu, S.
    INTERNAL MEDICINE JOURNAL, 2015, 45 : 42 - 42
12345